Randomized trial promoting cancer genetic risk assessment when genetic counseling cost removed: 1-year follow-up is a research paper published in JNCI Cancer Spectrum (2024). On theSindex it has a DataRank of 0.236. It has been cited 3 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0283
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
National Institutes of Health
Grant: R01CA211625
National Cancer Institute
Grant: 3P30CA072720
NCI NIH HHS
Grant: P30 CA072720
Rutgers Cancer Institute
National Cancer Institute
FWCI
1.17
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals